PARP inhibitors
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
PARP inhibitors
Jul 19, 2024, 12:31 |
Insight
Genetic Testing in Men With mCRPC
William Oh shared a post on LinkedIn about a recent paper by Pedro Barata et…
Jul 1, 2024, 13:29 |
Blog
Rodrigo Sánchez-Bayona: RWE study of ovarian cancer patients treated with PARP inhibitors at ESMO Gynaecological Cancers Congress 2024
Rodrigo Sánchez-Bayona, Medical Oncologist specialising in breast and gynecological cancers at 12 de Octubre University…
Jun 23, 2024, 14:41 |
Blog
Amol Akhade: P53 for endometrial cancer
Amol Akhade, Consultant Medical Oncologist atSuyog Cancer Clinics, shared a post on X: "P53 for endometrial…
Jun 17, 2024, 15:06 |
Dialogues
Oncodaily Dialogues #9 István Peták/ Hosted by Roupen Odabashian
In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…
Jun 9, 2024, 09:45 |
Societies
Chandler Park: A fun discussion at ASCO24 with David O’Malley
Chandler Park recently shared on X: "Dr. David O’Malley and I have a fun discussion…
May 21, 2024, 11:30 |
Societies
Register until 22 May for ESMO Gynae24 - ESMO
The European Society for Medical Oncology (ESMO) shared on LinkedIn: “Calling all Gynaecology Oncology Professionals, ESMO…
May 8, 2024, 23:17 |
Insight
Giampaolo Bianchini: Join us at the next ESMO Virtual Plenary session!
Elisa Agostinetto, Research Physician at Institute of Jules Bordet in Brussels, shared a post by Giampaolo…
May 6, 2024, 09:49 |
Insight
Wafik S. El-Deiry: RI Cancer Action Day
Wafik S. El-Deiry shared a post on LinkedIn: “Stopped by the Rhode Island Statehouse this afternoon…
Apr 30, 2024, 19:43 |
Insight
Erman Akkus: Our new study Prostate Cancer and PARPi
Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X: “Our…
Apr 17, 2024, 19:06 |
Drugs
New research from Dr. Jung-Min Lee has identified a potential drug to treat ovarian cancers - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "Milestones Monday: Ovarian cancer is the most lethal…
Mar 23, 2024, 23:31 |
Blog
Antonio Marra: Our review on current use and future development of PARP inhibitors in breast cancer just out in JAMA Oncology
Antonio Marra, Medical Oncologist at the European Institute of Oncology, on LinkedIn: “Excited to see…
Mar 22, 2024, 00:59 |
Insight
Sharlene Gill: Happy to share the inaugural issue of Canadian Oncology Today
Sharlene Gill shared on LinkedIn: "Vol 1, Issue 1: Happy to share the inaugural issue…
Feb 29, 2024, 14:42 |
Blog
Rasha Aboelhassan: Presenting updated NCCN Guidelines for epithelial ovarian cancer to a group of professionals and young oncologists was a rewarding experience
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn: “Presenting updated NCCN Guidelines for…
Jan 18, 2024, 15:12 |
Blog
Maria Natalia Gandur Quiroga: Immuno-Oncology Advances in Genitourinary Cancers
Maria Natalia Gandur Quiroga shared a post on LinkedIn: "Immuno-Oncology Advances in Genitourinary Cancers: Introduction:…
Dec 20, 2023, 11:19 |
Blog
Yüksel Ürün: PARP inhibitors in treating prostate cancer
Yüksel Ürün, Medical Oncologist at Ankara University, shared on X/Twitter: “Thrilled to share our latest…
Sep 3, 2023, 17:26 |
Opinion
Paz Polak: In a correspondence letter we wrote for the NEJM, we suggested that testing for POLE, and even better, checking for POLE-associated mutational signatures.
Paz Polak, VP of Computational Biology, C2i Genomics, recently posted on LinkedIn: "In a correspondence…
Aug 16, 2023, 13:39 |
Opinion
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani: The idea that early use of parp inhibitors would be beneficial, while late use would be harmful, lacks plausibility and a reasonable explanation.
All:
17
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube